The Lancet Oncology, March 2021, Volume 22, Issue 3, Pages 289-410, e82-e131
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China - The Lancet Oncology
The Lancet Top-Cited Content
Lancet Oncology, The impact factor and citations:... | Exaly
Cancer in sub-Saharan Africa: a Lancet Oncology Commission - The Lancet Oncology
Lancet Regional Health - Europe, The impact factor and... | Exaly
The Lancet Oncology on X: "The September issue of The Lancet Oncology is now available online - check it out at https://t.co/BNjH0EQNvk https://t.co/4mrG91uV2k" / X
The Lancet Oncology
The Lancet Regional Health - Europe: Home Page
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study - The Lancet Oncology
Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study - The Lancet Oncology
Cancer and climate change - The Lancet Oncology
The Lancet Oncology | Journal | ScienceDirect.com by Elsevier